Le Lézard
Classified in: Health
Subject: AVO

Do No Harm Releases Report Exposing Medical Schools for Skirting SCOTUS Ruling


Medical schools and organizations have made defiant statements against the Supreme Court's ban on race-based admissions 

RICHMOND, Va., May 16, 2024 /PRNewswire/ -- Prestigious medical schools continue to discriminate based on race and are committed to continue to find work arounds to the Supreme Court's ruling in Students for Fair Admissions v. Harvard and Students for Fair Admissions v. North Carolina are the findings in a report released today by Do No Harm.

The report reveals prestigious medical schools such as Stanford made defiant statements in wake of the ruling: "Stanford Medicine firmly believes in the transformative power of diversity, in all dimensions... While the ruling changes the landscape of university admissions, it does not change our resolve or our values. We reaffirm that commitment to you today and in the days to come." 

In addition to Stanford, leading medical organizations also were dissatisfied with the court curtailing their political agenda. The report warns the Association of American Medical Colleges (AAMC), a group with a track record of forcing progressive political agendas into the accreditation process, could attempt to compel medical schools to follow the AAMC's politized DEI standards. 

"Abolishing DEI at medical schools is also instrumental in redirecting admissions committees toward merit and aptitude rather than identity politics. DEI corrupts all facets of academic life and compels a fixation on group representation, including within the admissions process." said Dr. Stanley Goldfarb, Chairman of Do No Harm.

Click here to read the report in its entirety. 

About Do No Harm: 

Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 7,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 7,800 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances. 

SOURCE Do No Harm


These press releases may also interest you

at 20:05
Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced that Cuthbert Simpkins MD, FACS,...

at 20:04
On 24 May 2024, Bidco and K1 announced that the offer document (the "Offer Document") in relation to Bidco's offer to acquire the entire issued and to be issued share capital of MariaDB plc (the "Offer") had been...

at 19:45
Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to present groundbreaking research on radiogenomics and homologous recombination deficiency (HRD) in breast cancer at the American Society of...

at 19:38
Numinus Wellness Inc. ("Numinus" or the "Company") , a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is pleased to announce the...

at 19:35
SterlingBio, a leading US woman-owned Contract Research Organization (CRO), is thrilled to announce that it has secured exclusive global distribution rights for SureClinical's cutting-edge eClinical apps, platform, and cloud, including the management...

at 19:05
Summit Therapeutics Inc. ("Summit," "we," or the "Company") announced that, on May 24, 2024, our partner, Akeso Inc. (Akeso, HKEX Code: 9926.HK), received marketing authorization in China from the National Medical Products Administration (NMPA). The...



News published on and distributed by: